CYP19A1 and cancer: In response to this need, the American Society of Clinical Oncology (ASCO) and the Society for Integrative Oncology (SIO) jointly released guidelines in 2022 recommending acupuncture as an evidence-based complementary therapy for managing cancer-related pain, particularly for aromatase inhibitor-related joint pain and general musculoskeletal pain [7,8,9].